ADI:NASDAQAnalog Devices, Inc. Analysis
Data as of 2026-03-09 - not real-time
$319.71
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Analog Devices delivered a spectacular earnings beat, posting Q4 CY2025 revenue of $3.16 billion—a 30.4% year‑over‑year increase—and Q1 FY2026 EPS of $2.46 versus consensus $2.31. Management also raised Q1 revenue guidance to $3.5 billion, roughly 8% above analyst expectations, and Barclays upgraded the stock to an overweight stance, reinforcing the bullish earnings narrative.
Technically, the stock trades at $319.71, sitting above the 50‑day SMA (315.65) but below the 20‑day SMA (340.91), with a neutral RSI of 41.9 and a bearish MACD histogram. The beta of 1.58 and 30‑day volatility of 33.6% signal heightened market sensitivity, while the dividend yield of 1.29% and a 72% payout ratio remain supported by robust free cash flow of $4.14 billion. Valuation is mixed: the DCF fair value of $312.77 suggests a slight premium on price, the trailing PE of 58.6 is well above the industry average of 36.9, yet the forward PE of 24.8 and analyst median target of $400 imply considerable upside.
Technically, the stock trades at $319.71, sitting above the 50‑day SMA (315.65) but below the 20‑day SMA (340.91), with a neutral RSI of 41.9 and a bearish MACD histogram. The beta of 1.58 and 30‑day volatility of 33.6% signal heightened market sensitivity, while the dividend yield of 1.29% and a 72% payout ratio remain supported by robust free cash flow of $4.14 billion. Valuation is mixed: the DCF fair value of $312.77 suggests a slight premium on price, the trailing PE of 58.6 is well above the industry average of 36.9, yet the forward PE of 24.8 and analyst median target of $400 imply considerable upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat and strong revenue guidance
- Price near technical support with bearish MACD
- Stable trading volume and solid cash flow
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Continued 30%+ YoY revenue growth
- Analyst upgrades and median target price of $400
- Forward earnings expansion (forward EPS $12.90) reducing valuation pressure
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained high gross and operating margins
- Strong free cash flow supporting dividend and reinvestment
- Strategic positioning in high‑growth semiconductor markets
Key Metrics & Analysis
Financial Health
Revenue Growth30.40%
Profit Margin23.02%
P/E Ratio58.6
ROE7.86%
ROA4.54%
Debt/Equity25.75
P/B Ratio4.6
Op. Cash Flow$5.1B
Free Cash Flow$4.1B
Industry P/E36.8
Technical Analysis
TrendBullish
RSI41.9
Support$307.22
Resistance$363.20
MA 20$340.91
MA 50$315.65
MA 200$259.77
MACDBearish
VolumeStable
Fear & Greed Index100
Valuation
Fair Value$312.77
Target Price$383.06
Upside/Downside19.82%
GradeFair
TypeGrowth
Dividend Yield1.29%
Risk Assessment
Beta1.58
Volatility33.57%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.